Business

Mass. Movers

Post-acquisition, Cynosure loses $1.3m

Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.

Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.

Advertisement

Cynosure Inc. reported a net loss of $1.3 million, or 6 cents per share, including acquisition costs for Palomar, which it purchased in June. Excluding those costs, earnings per share were 23 cents. Revenue of $60.7 million, while up 64 percent, fell short of the consensus estimate of $61.6 million. It was the first full quarter for the combined company. CEO Michael Davin said the acquisition remains on track to achieve $8 million to $10 million in cost synergies.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com